Considering the lack of prognostic markers in lung cancer and looking for accessible and feasible markers which could provide clinicians with prognostic data, the LKB1 expression might be helpful in contexts like LATAM, which are without broad access to next-generation sequencing. Here, STK11 is linked to lung carcinoma.